Furthermore, centrally administered leptin effectively decreases the rate of fat accumulation, hyperglycemia, insulin resistance, hyperinsulinemia, and progression to metabolic syndrome in obese rodents [28–30]. This evidence concerns the gene LEP and metabolic syndrome.